Aclaris Therapeutics, Inc.

Aclaris Therapeutics is a biopharmaceutical company dedicated to developing novel, small molecule therapies for immuno-inflammatory conditions. Their focus lies in leveraging expertise in drug discovery and development, particularly in kinase inhibition, to address unmet needs in these disease areas. They utilize their proprietary KINect® technology platform, which differentiates them from competitors through its ability to systemically and efficiently attach human kinases. This platform has generated clinical candidates for difficult-to-drug kinases, offering new approaches to treating chronic inflammation and autoimmune diseases.

Aclaris is committed to building a rewarding workplace where collaboration, initiative, and energy are valued. They offer a competitive compensation and benefits package, including excellent health benefits, generous time off, and a 401(K) savings plan with a generous employer match. They are an equal opportunity employer, committed to advancing innovation in immuno-inflammatory conditions and empowering patients with new treatment options.

Aclaris Therapeutics provides a competitive compensation and benefits package that includes excellent health benefits, covering medical, dental, and vision plans with majority of monthly premium paid by the company. Additionally, employees receive employer-paid life, short-term disability, and long-term disability insurance. A generous time-off policy, paid holidays, flexible spending accounts, an employee assistance program, and a 401(K) savings plan with a generous employer match are also included. There is also an employee referral program.

Aclaris Therapeutics is a biopharmaceutical company focused on developing novel, small molecule therapies to address underserved immuno-inflammatory conditions. They leverage their expertise in drug discovery and development, particularly in kinase inhibition, to create innovative treatments for conditions like rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, and inflammatory bowel disease. Aclaris' mission is to translate scientific discovery into everyday victories for patients suffering from these often chronic and debilitating conditions.

Aclaris Therapeutics promotes a culture that values innovation, collaboration, and a strong sense of purpose. The company is committed to addressing underserved conditions and empowers its employees to be visionary, skilled, results-driven, and empathetic. This dedication to patient-centricity and professional integrity creates a collaborative and rewarding work environment where individuals are encouraged to take initiative, contribute their diverse talents, and make a meaningful difference in the lives of patients.

Aclaris Therapeutics is committed to diversity, equity, and inclusion, recognizing the value of a varied workforce. They are an equal opportunity employer, ensuring all qualified applicants are considered for employment regardless of race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, protected veteran status, or other legally protected characteristics. Aclaris also actively seeks to bridge the gap in underrepresented minorities within the STEM workforce through their partnership with Harris-Stowe State University, providing internships and potential employment opportunities to students from diverse backgrounds.